Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
AMGN reported that AMG 108 failed to meet its primary endpoint in a Phase II trial. AMGN did not disclose the endpoint. The company said it plans to continue development of AMG 108 in other inflammato...
